Health Condition 1: null- Uterine Fibroids
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Symptomatic Females, 25-50 yrs Uterine fibroids, uterine size 2 cm but none >5 cm on U/S Pre menopausal ladies with Uterine Fibroids getting at least 1 menstrual period in last three months. Normal PAP smear.
Exclusion criteria
Exclusion criteria: Pregnancy, Lactation. Unexplained vaginal bleeding, cervical dysplasia, abnormal ovarian or adnexal mass. History of malignancy within the past 5 years. Use of estrogen or progesterone-containing compounds, such as oral contraceptives and hormone replacement therapy, within 8 weeks of study entry, including transdermal, injectable, vaginal and oral preparations. Use of herbal medication having estrogenic or antiestrogenic effect within the past 3 months. Known recent rapid growth of fibroids, defined as a doubling in size in six months. Haemoglobin level below 8gm% Patients suffering from any other major systemic illness necessitating long term drug Therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the clinical symptomsTimepoint: At base line 30th day, 60th day, 90th day, 120th day, 150th day and 180th day i.e at the time of trial completion | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the size of fibroidsTimepoint: At the screening day, 90th day and end of the study (180th day) | — |
Countries
India
Contacts
Ayurveda Research Institute for Mother and Child Health care